Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
A new app allows patients with rheumatic and musculoskeletal diseases to choose which measures of disease activity to track—and the results can help direct personalized treatment.
The ACR and EULAR updated their criteria for classifying systemic lupus erythematosus in 2019. How did the newer criteria perform compared with earlier systems of classification? Read more to find out. ...
Researchers compared rates of in-hospital mortality among patients with and without systemic lupus erythematosus to determine the trends and risk factors associated with death related to SLE.
Researchers conducted a literature review to find out whether existing predictive tools accurately predict whether patients with rheumatic diseases will develop cardiovascular diseases.
Because immunometabolism is involved in the pathogenesis of SLE, the researchers aimed to determine whether repurposing metformin could control the immunometabolic processes in patients with systemic lupus...
In a new population-based study, the authors sought to assess the risk of hypersensitivity reactions with allopurinol and febuxostat use among persons aged 65 years or older.
